The fact
This situation suggests a possible short-term rebound for contrarian investors.
The biotech laboratory's shares remain volatile with mixed signals for short-term traders.
22 sources — click a link to read an article on the topic:
Story timeline
Apr 13Valneva: bearish position but stock oversold says Boursoramathis article